<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新康界 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-09T20:33:10+08:00</updated>
  <subtitle>中康资讯旗下品牌，中国领先的医药健康产业财经新媒体。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>医药新股破发频频，投资逻辑生变？</title>
    <updated>2020-11-09T19:31:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/qRNYTmSBeWOyFAlrnn8VZA</id>
    <link href="https://mp.weixin.qq.com/s/qRNYTmSBeWOyFAlrnn8VZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一名分析师眼中医药股的过去10年和未来10年</title>
    <updated>2020-11-09T19:31:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/kAPw8qNFyM2nO2yos4b1rg</id>
    <link href="https://mp.weixin.qq.com/s/kAPw8qNFyM2nO2yos4b1rg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：进博会带量采购意向签约超8亿，康龙化成收购美国CRO</title>
    <updated>2020-11-09T19:31:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/0_cTw1j0nUmlPg-zRvf8Dw</id>
    <link href="https://mp.weixin.qq.com/s/0_cTw1j0nUmlPg-zRvf8Dw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>价值研判！未来2-3年，这6只医药股或冲上千亿市值！</title>
    <updated>2020-11-08T00:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/wpzgsSSjZsDW7ucPel9z3g</id>
    <link href="https://mp.weixin.qq.com/s/wpzgsSSjZsDW7ucPel9z3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CXO泡沫浴：分享创新药红利的最好方式</title>
    <updated>2020-11-08T00:45:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/mPu8u6eIBECh6GeykkyX9g</id>
    <link href="https://mp.weixin.qq.com/s/mPu8u6eIBECh6GeykkyX9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>案例说：制药企业的转型路径</title>
    <updated>2020-11-07T18:30:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-07:/s/AWrmBa_uFm5ZAWWN7Sw56w</id>
    <link href="https://mp.weixin.qq.com/s/AWrmBa_uFm5ZAWWN7Sw56w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞、正大天晴、泽璟已布局：喜忧参半的JAK抑制剂</title>
    <updated>2020-11-06T17:54:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/_cXW6_7ifPQJS1kXzMUSUg</id>
    <link href="https://mp.weixin.qq.com/s/_cXW6_7ifPQJS1kXzMUSUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架集采脚踝斩，医疗器械未来悲观吗？</title>
    <updated>2020-11-06T17:54:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/lcnuFO0f32xSHiaZopycAQ</id>
    <link href="https://mp.weixin.qq.com/s/lcnuFO0f32xSHiaZopycAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：艾博生物获1.5亿元A轮融资，冠脉支架集采价格低至469元</title>
    <updated>2020-11-06T17:54:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-06:/s/c3K1boDLs7mKBQv51a4_bw</id>
    <link href="https://mp.weixin.qq.com/s/c3K1boDLs7mKBQv51a4_bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冠脉支架报价结果抢先看：降幅90%！三款进口产品入围！</title>
    <updated>2020-11-05T12:03:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/UmP06mpdUPp_MEM49b6D5g</id>
    <link href="https://mp.weixin.qq.com/s/UmP06mpdUPp_MEM49b6D5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医疗是中美之间实力差距最大的产业？——从世界五百强对比中美两国产业实力</title>
    <updated>2020-11-04T19:41:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/9PJ8SKZdN97S_VSrsGpjRA</id>
    <link href="https://mp.weixin.qq.com/s/9PJ8SKZdN97S_VSrsGpjRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>六千亿药明系三号种子来势汹汹，竟成今年首家首日破发的冠B医药企业？</title>
    <updated>2020-11-03T19:26:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/nOgNuT7f5kQs3h8HxpVxHg</id>
    <link href="https://mp.weixin.qq.com/s/nOgNuT7f5kQs3h8HxpVxHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大健康产业投资并购动态周报Vol.24</title>
    <updated>2020-11-03T19:26:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/dbarU7Ds8WPpMF1zEJc3VA</id>
    <link href="https://mp.weixin.qq.com/s/dbarU7Ds8WPpMF1zEJc3VA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：​老百姓获国际金融公司10亿元长期贷款，医保局发文推进“互联网+”医疗服务</title>
    <updated>2020-11-03T19:26:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/TmbZmgk9hpC29Vwms2R5Fw</id>
    <link href="https://mp.weixin.qq.com/s/TmbZmgk9hpC29Vwms2R5Fw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>带你看医药生物行业财报之——哪些最“败”“金”？</title>
    <updated>2020-11-01T22:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/lXNJ7IuKThg8J0gUbbDaHA</id>
    <link href="https://mp.weixin.qq.com/s/lXNJ7IuKThg8J0gUbbDaHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>广誉远财报解读：终端销售逐渐恢复，头部私募率先入局</title>
    <updated>2020-11-01T22:27:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/I5EfM0aMFZaRVcXBs-7Sww</id>
    <link href="https://mp.weixin.qq.com/s/I5EfM0aMFZaRVcXBs-7Sww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四大药店三季报火线解读！各有千秋你pick哪一家？</title>
    <updated>2020-10-31T22:11:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/RgeEttlDX5oRyuQiP8cPPQ</id>
    <link href="https://mp.weixin.qq.com/s/RgeEttlDX5oRyuQiP8cPPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全面解读：从A股、港股、美股看生物医药企业的研发投入</title>
    <updated>2020-10-30T19:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/lkiPS6E6duqoSNW-Y0lEZg</id>
    <link href="https://mp.weixin.qq.com/s/lkiPS6E6duqoSNW-Y0lEZg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中康CMH| 2020年上半年药品零售行业走势——集采之下药品零售之破局</title>
    <updated>2020-10-30T19:03:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/UTupe-fC7tH8-yYiSHaPMg</id>
    <link href="https://mp.weixin.qq.com/s/UTupe-fC7tH8-yYiSHaPMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>